Medical Education Grants
InterMune provides support for independent medical education programs that address unmet educational needs in a clinical area of interest.
-
Pirfenidone is the Only Medicine Approved for the Treatment of IPF Anywhere in the World
-
We are Leading the World in Research & Development for Idiopathic Pulmonary Fibrosis
-
Bringing Hope to Patients Who Currently Have No Treatment Options
InterMune's
Core Values
We are a values-driven company that works to embody Integrity, Passion, Accountabilitity, Creativity, and Teamwork in the pursuit of our mission.
IPF and InterMune featured on the Balancing Act® on Lifetime TV®
InterMune’s Dr. Bill Bradford talks about the latest research in IPF, and patient Bob Williams and his daughter share their experiences in living with the disease.
IPF and InterMune Featured on the Balancing Act® on Lifetime TV®
© InterMune 2013. All rights reserved.
built@zoomedia
